SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-002336
Filing Date
2024-01-09
Accepted
2024-01-09 16:56:14
Documents
15
Period of Report
2024-01-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea191405-8k425_10xcap3.htm   iXBRL 8-K 46360
2 JOINDER TO THE LETTER AGREEMENT, DATED JANUARY 9, 2024, BETWEEN 10X III, THE SPO ea191405ex10-1_10xcap3.htm EX-10.1 9302
3 PRESS RELEASE, DATED JANUARY 8, 2024 ea191405ex99-1_10xcap3.htm EX-99.1 11371
  Complete submission text file 0001213900-24-002336.txt   307517

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE vcxb-20240108.xsd EX-101.SCH 4221
5 XBRL DEFINITION FILE vcxb-20240108_def.xml EX-101.DEF 27375
6 XBRL LABEL FILE vcxb-20240108_lab.xml EX-101.LAB 38062
7 XBRL PRESENTATION FILE vcxb-20240108_pre.xml EX-101.PRE 25995
9 EXTRACTED XBRL INSTANCE DOCUMENT ea191405-8k425_10xcap3_htm.xml XML 7079
Mailing Address 1 WORLD TRADE CENTER FLOOR 85 NEW YORK NY 10007
Business Address 1 WORLD TRADE CENTER FLOOR 85 NEW YORK NY 10007 (212) 257-0069
10X Capital Venture Acquisition Corp. III (Filer) CIK: 0001848948 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41216 | Film No.: 24523912
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)